These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 16596227)

  • 1. Pilot study examining tumor expression of RAD51 and clinical outcomes in human head cancers.
    Connell PP; Jayathilaka K; Haraf DJ; Weichselbaum RR; Vokes EE; Lingen MW
    Int J Oncol; 2006 May; 28(5):1113-9. PubMed ID: 16596227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential regulation of DNA repair protein Rad51 in human tumour cell lines exposed to doxorubicin.
    Koehn H; Magan N; Isaacs RJ; Stowell KM
    Anticancer Drugs; 2007 Apr; 18(4):419-25. PubMed ID: 17351394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 172G>T variant in the 5' untranslated region of DNA repair gene RAD51 reduces risk of squamous cell carcinoma of the head and neck and interacts with a P53 codon 72 variant.
    Lu J; Wang LE; Xiong P; Sturgis EM; Spitz MR; Wei Q
    Carcinogenesis; 2007 May; 28(5):988-94. PubMed ID: 17118968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of the microenvironment of head and neck cancers on tumor progression].
    Lukits J
    Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excision repair cross complementation group 1 immunohistochemical expression predicts objective response and cancer-specific survival in patients treated by Cisplatin-based induction chemotherapy for locally advanced head and neck squamous cell carcinoma.
    Handra-Luca A; Hernandez J; Mountzios G; Taranchon E; Lacau-St-Guily J; Soria JC; Fouret P
    Clin Cancer Res; 2007 Jul; 13(13):3855-9. PubMed ID: 17606717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Split course hyperfractionated accelerated radio-chemotherapy (SCHARC) for patients with advanced head and neck cancer: influence of protocol deviations and hemoglobin on overall survival, a retrospective analysis.
    Stadler P; Putnik K; Kreimeyer T; Sprague LD; Koelbl O; Schäfer C
    BMC Cancer; 2006 Dec; 6():279. PubMed ID: 17150114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of radiation therapy for the control of Merkel cell carcinoma of the head and neck based on 36 cases and a literature review.
    Lawenda BD; Arnold MG; Tokarz VA; Silverstein JR; Busse PM; McIntyre JF; Deschler DG; Baldini EH; Kachnic LA
    Ear Nose Throat J; 2008 Nov; 87(11):634-43. PubMed ID: 19006065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer.
    Nguyen NP; Vos P; Lee H; Borok TL; Karlsson U; Martinez T; Welsh J; Cohen D; Hamilton R; Nguyen N; Nguyen LM; Vinh-Hung V
    Oncology; 2008; 75(3-4):186-91. PubMed ID: 18841033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression in tumor-adjacent normal tissue is associated with recurrence in patients with rectal cancer treated with adjuvant chemoradiation.
    Schneider S; Park DJ; Yang D; El-Khoueiry A; Sherrod A; Groshen S; Streeter O; Iqbal S; Danenberg KD; Lenz HJ
    Pharmacogenet Genomics; 2006 Aug; 16(8):555-63. PubMed ID: 16847424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA damage and repair in gastric cancer--a correlation with the hOGG1 and RAD51 genes polymorphisms.
    Poplawski T; Arabski M; Kozirowska D; Blasinska-Morawiec M; Morawiec Z; Morawiec-Bajda A; Klupińska G; Jeziorski A; Chojnacki J; Blasiak J
    Mutat Res; 2006 Oct; 601(1-2):83-91. PubMed ID: 16843501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HSV-1 amplicon-mediated post-transcriptional inhibition of Rad51 sensitizes human glioma cells to ionizing radiation.
    Saydam O; Saydam N; Glauser DL; Pruschy M; Dinh-Van V; Hilbe M; Jacobs AH; Ackermann M; Fraefel C
    Gene Ther; 2007 Aug; 14(15):1143-51. PubMed ID: 17495946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the RAD51 G172T polymorphism in the clinical outcome of cervical cancer patients under concomitant chemoradiotherapy.
    Nogueira A; Catarino R; Faustino I; Nogueira-Silva C; Figueiredo T; Lombo L; Hilário-Silva I; Pereira D; Medeiros R
    Gene; 2012 Aug; 504(2):279-83. PubMed ID: 22634097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of Rad51 protein levels by p38 MAPK decreases cytotoxicity and mutagenicity in benzo[a]pyrene-exposed human lung cancer cells.
    Chuang SM; Wang LH; Hong JH; Lin YW
    Toxicol Appl Pharmacol; 2008 Aug; 230(3):290-7. PubMed ID: 18430445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The BRCA1/BRCA2/Rad51 complex is a prognostic and predictive factor in early breast cancer.
    Söderlund K; Skoog L; Fornander T; Askmalm MS
    Radiother Oncol; 2007 Sep; 84(3):242-51. PubMed ID: 17707537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of TESTIN and its association with cancer history and a tendency toward poor survival in head and neck squamous cell carcinoma.
    Gunduz E; Gunduz M; Beder L; Nagatsuka H; Fukushima K; Sutcu R; Delibas N; Yamanaka N; Shimizu K; Nagai N
    Arch Otolaryngol Head Neck Surg; 2009 Mar; 135(3):254-60. PubMed ID: 19289703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of prognostic factors and two radiation techniques in patients treated with surgery followed by radio(chemo)therapy or definitive radio(chemo)therapy for locally advanced head-and-neck cancer.
    Rades D; Stoehr M; Meyners T; Bohlen G; Nadrowitz R; Dunst J; Schild SE; Wroblewski J; Albers D; Schmidt R; Alberti W; Tribius S
    Strahlenther Onkol; 2008 Apr; 184(4):198-205. PubMed ID: 18398584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival in patients with synovial sarcoma of the head and neck: association with tumor location, size, and extension.
    Harb WJ; Luna MA; Patel SR; Ballo MT; Roberts DB; Sturgis EM
    Head Neck; 2007 Aug; 29(8):731-40. PubMed ID: 17274049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-nucleotide polymorphisms in DNA double-strand break repair genes: association with head and neck cancer and interaction with tobacco use and alcohol consumption.
    Werbrouck J; De Ruyck K; Duprez F; Van Eijkeren M; Rietzschel E; Bekaert S; Vral A; De Neve W; Thierens H
    Mutat Res; 2008 Oct; 656(1-2):74-81. PubMed ID: 18768166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term neck control rates after complete response to chemoradiation in patients with advanced head and neck cancer.
    Rengan R; Pfister DG; Lee NY; Kraus DH; Shah JP; Shaha AR; Ben-Porat LS; Zelefsky MJ
    Am J Clin Oncol; 2008 Oct; 31(5):465-9. PubMed ID: 18838883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.
    Haddad R; Sonis S; Posner M; Wirth L; Costello R; Braschayko P; Allen A; Mahadevan A; Flynn J; Burke E; Li Y; Tishler RB
    Cancer; 2009 Oct; 115(19):4514-23. PubMed ID: 19634161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.